Open AccessMetabolic Syndrome in Polycystic Ovary Syndrome
Author(s) -
Yun-Chiao Hsieh,
PeiChi Yang,
Mei-Jou Chen
Publication year - 2021
Publication title -
fertility and reproduction
Language(s) - English
Resource type - Journals
eISSN - 2661-3182
pISSN - 2661-3174
DOI - 10.1142/s2661318221500158
Subject(s) - polycystic ovary , hyperandrogenism , anovulation , dyslipidemia , metabolic syndrome , insulin resistance , medicine , type 2 diabetes mellitus , obesity , endocrinology , diabetes mellitus , bioinformatics , biology
Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women of reproductive age. Although its essential clinical manifestation includes a plethora of symptoms and signs, which largely reflects the underlying hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology, PCOS may also be associated with many metabolic derangements. These metabolic derangements happen to overlap with many of the core constituents of the metabolic syndrome (MBS)—increased insulin resistance, central obesity, and dyslipidemia. The two disorders also display similarly increased risks for certain metabolic and vascular diseases, such as type 2 diabetes mellitus, hypertension, and cardiovascular diseases. Due to the many similarities between metabolic syndrome and PCOS, this review aims to examine the evidence concerning the overlapping features, the risks for comorbidities, possible shared mechanisms, and treatment strategies in patients with coexisting PCOS and MBS.